Reade A De Leacy, MD Email Reade De Leacy
-
- Positions
- ASSOCIATE PROFESSOR | Neurosurgery
- ASSOCIATE PROFESSOR | Diagnostic, Molecular and Interventional Radiology
-
- Specialties
- Neuroradiology
- Neurosurgery
- Radiology
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Queens
- Mount Sinai Brooklyn
-
- Phone
- The Mount Sinai Hospital 212-241-1297 212-241-1297
- Mount Sinai West 212-241-1297 212-241-1297
- Mount Sinai Queens 212-241-1297 212-241-1297
-
The Mount Sinai Hospital
Klingenstein Clinical Center, 1-North
1450 Madison Avenue
New York, NY 10029
Phone: 212-241-1297212-241-1297 -
Mount Sinai Queens
25-20 30th Avenue
Fifth Floor, Ambulatory Pavilion
Astoria, NY 11102
Phone: 212-241-1297212-241-1297
Reade De Leacy, MD, is the Director of the Neurointerventional Spine Program and Associate Professor of Neurosurgery and Radiology in the Cerebrovascular Center at The Mount Sinai Hospital. Additionally, he serves as Director of Cerebrovascular Services at Mount Sinai Queens.
A specialist in diagnostic and interventional radiology, Dr. De Leacy is board certified in both diagnostic radiology and neuroradiology by the American Board of Radiology. He completed his fellowship trainings in neuroendovascular surgery and neurointerventional radiology under the tutelage of J Mocco, MD, MS, and Alejandro Berenstein, MD, as well as a fellowship in diagnostic neuroradiology at The Mount Sinai Hospital. He also completed fellowship training in general interventional radiology at St. Vincent’s Hospital in Melbourne, Australia and in musculoskeletal MRI at Qscan Radiology Clinics in Brisbane, Australia.
Dr. De Leacy obtained his medical degree and graduated with honors from the University of Queensland, Australia. In 2012, he completed his specialist training becoming a fellow of the Royal Australian and New Zealand College of Radiologists, where he earned the prestigious Uhr Clarke Bursary and HR Sear Prize awards as the highest-ranked graduate from both diagnostic radiology and radiation oncology in Australia, New Zealand, and Singapore.
Dr. De Leacy has published multiple peer-reviewed journal articles and book chapters in diagnostic neuroradiology, interventional radiology, and neuroendovascular surgery.
Dr. De Leacy specializes in the endovascular treatment of cerebrovascular disorders including acute stroke, carotid stenosis, brain aneurysms, arteriovenous malformations, and minimally invasive spinal surgeries including biopsy, kyphoplasty, and ablative therapy for spinal and paraspinal tumors.
In 2020, Dr. De Leacy was a recipient of the Mount Sinai Cullman Family Award for Excellence in Physician Communication.
IN THE NEWS
EMT Who Suffered Stroke Leaves New York City Hospital Just in Time for Thanksgiving (WABC-TV)
Certification
Diagnostic Radiology
Clinical Focus
- Aneurysm Coiling
- Arteriovenous Malformation of the Brain
- Biopsy
- Brain Aneurysm
- Brain Tumor Imaging
- CT Scan Of The Head
- Carotid Artery Stenosis
- Carotid Stenting
- Cerebral Vasospasm
- Dural Arteriovenous Fistula (DAVF)
- Endovascular Embolization
- Hemangioma
- Magnetic Resonance Angiography
- Magnetic Resonance Imaging
- Mechanical Thrombectomy
- Minimally Invasive Spine Surgery
- Radiology
- Sclerotherapy
- Spinal Vascular Malformations
- Stroke
- Subarachnoid Hemorrhage
- Vascular Malformations
- Venous Sinus Thrombosis
- Venous Thrombosis
Education
MD, University of Queensland
Fellowship, Royal Australian and New Zealand College of Radiologists
Fellowship Specialist, Royal Australian and New Zealand College of Radiologists
Residency
Gold Coast Hospital
Residency, Radiology
Princess alexandra hospital
Internship
Gold Coast Hospital
Fellowship, Neuroradiology
Mount Sinai Hospital
Fellowship, Neurosurgery
Mount Sinai Hospital
Language
English
2011
HR Sear Award
The Royal Australian and New Zealand College of Radiologists
2011
Uhr Clarke Bursary Award (QLD Branch Award)
The Royal Australian and New Zealand College of Radiologists
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. De Leacy during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Imperative Care
- Penumbra, Inc.
- Proxima CRO
- Siemens
- Stryker Corporation
- imperative care
- medical metrics
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Endostream
- Q'Apel
- Spartan Micro
- Synchron
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.